Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Cirrhosis”

351 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 351 results

Not applicableStudy completedNCT00059267
What this trial is testing

Prevention of Recurrent Hepatitis B After Liver Transplantation

Who this might be right for
Hepatitis BCirrhosisAcute Liver Failure+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 317
Not applicableNot Yet RecruitingNCT07087041
What this trial is testing

Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests

Who this might be right for
Decompensated CirrhosisHepatitis B Virus (HBV) InfectionMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)+3 more
Beijing Friendship Hospital 735
Not applicableStudy completedNCT02060162
What this trial is testing

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

Who this might be right for
Hepatitis B VirusHIVAntiretroviral Therapy+3 more
University of Alabama at Birmingham 897
Not applicableStudy completedNCT02636608
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary

Who this might be right for
Chronic Hepatitis C
AbbVie 244
Not applicableUnknownNCT00160940
What this trial is testing

Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis

Who this might be right for
Hepatitis CHepatitis BAutoimmune Hepatitis+2 more
University Health Network, Toronto 200
Testing effectiveness (Phase 2)Study completedNCT02993250
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 33
Testing effectiveness (Phase 2)Study completedNCT02765490
What this trial is testing

Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 365
Not applicableStudy completedNCT01962155
What this trial is testing

Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters

Who this might be right for
Hepatitis BLiver Fibrosis
Peking University First Hospital 1,841
Not applicableLooking for participantsNCT06586983
What this trial is testing

Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia

Who this might be right for
Hepatitis B
Oslo University Hospital 4,500
Testing effectiveness (Phase 2)UnknownNCT00281502
What this trial is testing

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyHepatitis CLiver Cirrhosis
Weill Medical College of Cornell University 50
Not applicableWithdrawnNCT05649202
What this trial is testing

Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)

Who this might be right for
Chronic HIV Infection
Assistance Publique - Hôpitaux de Paris
Post-approval studies (Phase 4)Study completedNCT02128542
What this trial is testing

Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 66
Not applicableUnknownNCT01720238
What this trial is testing

Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis

Who this might be right for
Liver CirrhosisHepatitis B
Beijing Friendship Hospital 621
Post-approval studies (Phase 4)Study completedNCT02168361
What this trial is testing

The SIM-SOF Trial for Hepatitis C

Who this might be right for
Chronic Hepatitis C
Center For Hepatitis C, Atlanta, GA 93
Testing effectiveness (Phase 2)UnknownNCT03067883
What this trial is testing

Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients

Who this might be right for
Chronic Hepatitis c
Ain Shams University 40
Large-scale testing (Phase 3)Study completedNCT02167945
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 615
Not applicableUnknownNCT01360879
What this trial is testing

Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease

Who this might be right for
Chronic Hepatitis BChronic Hepatitis C
Kindai University 500
Large-scale testing (Phase 3)Study completedNCT03219216
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 100
Post-approval studies (Phase 4)UnknownNCT04939441
What this trial is testing

Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)

Who this might be right for
Chronic Hepatitis B
Jidong Jia 100
Large-scale testing (Phase 3)Study completedNCT00048724
What this trial is testing

Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)

Who this might be right for
Chronic Hepatitis CCirrhosis
Merck Sharp & Dohme LLC 631
Next Page